CA Patent

CA3022497A1 — Treatment of liver, biliary tract and pancreatic disorders

Assigned to Novozymes AS · Expires 2017-11-02 · 9y expired

What this patent protects

The present invention relates to methods for treatment or prevention of liver, biliary tract, and pancreatic disorders by administering one or more defensins. Included within the scope of the disclosure is also treatment of certain metabolic disorders.

USPTO Abstract

The present invention relates to methods for treatment or prevention of liver, biliary tract, and pancreatic disorders by administering one or more defensins. Included within the scope of the disclosure is also treatment of certain metabolic disorders.

Drugs covered by this patent

Patent Metadata

Patent number
CA3022497A1
Jurisdiction
CA
Classification
—
Expires
2017-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Novozymes AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.